Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020805
Company: SANDOZ
Company: SANDOZ
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CIPRO HC | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE | EQ 0.2% BASE;1% | SUSPENSION/DROPS;OTIC | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 02/10/1998 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20805-mr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20805-mr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20805.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/20/2017 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020805s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020805Orig1s011ltr.pdf | |
| 07/09/2013 | SUPPL-10 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 03/13/2002 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
| 04/19/2001 | SUPPL-5 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
| 02/27/2001 | SUPPL-4 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
||
| 10/14/1999 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
| 09/17/1998 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
| 09/15/1998 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/20/2017 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020805s011lbl.pdf | |
| 02/10/1998 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20805-mr.pdf |
CIPRO HC
SUSPENSION/DROPS;OTIC; EQ 0.2% BASE;1%
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| CIPRO HC | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE | EQ 0.2% BASE;1% | SUSPENSION/DROPS;OTIC | Prescription | Yes | AB | 020805 | SANDOZ |
| CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE | EQ 0.2% BASE;1% | SUSPENSION/DROPS;OTIC | Prescription | No | AB | 218273 | COSETTE PHARMS NC |